Compound ID | 1332
Class: Cationic glycopolymer
Spectrum of activity: | Gram-negative |
Institute where first reported: | Townsend Bio-Pharm Consulting, Rancho Cucamonga, California, USA |
Highest developmental phase: | Preclinical |
External links: | |
Citation: | https://aac.asm.org/content/63/6/e00498-19 |